Previous close | 40.64 |
Open | 40.00 |
Bid | 38.88 x 100 |
Ask | 39.06 x 100 |
Day's range | 38.68 - 40.44 |
52-week range | 24.46 - 48.68 |
Volume | |
Avg. volume | 203,074 |
Market cap | 1.787B |
Beta (5Y monthly) | 1.08 |
PE ratio (TTM) | 6.13 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.36 (0.92%) |
Ex-dividend date | 14 June 2024 |
1y target est | N/A |
Merchants Bancorp's (MBIN) diverse revenue streams, solid loan pipeline and strong balance sheet are likely to aid its financials. This makes the stock an attractive pick for investors.
Merchants Bancorp (MBIN) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
ADMA Biologics, Northern Technologies, PlayAGS, Merchants Bank and Strategic Education have been highlighted in this Screen of The Week article.